Madhu Dhar

Dr. Madhu Dhar

Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2014 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
Hoda ElkhenanyHoda Elkhenany
Hoda Elkhenany
LALisa Amelse
Lisa Amelse
ALAndersen Lafont
Andersen Lafont
SBShawn Bourdo
Shawn Bourdo
MCMarc Caldwell
Marc Caldwell
Madhu DharMadhu Dhar
Madhu Dhar

1 May 2004 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
YWYanxin Wang
Yanxin Wang
SUSumithra Urs
Sumithra Urs
SKSuyeon Kim
Suyeon Kim
MSMorvarid Soltani-Bejnood
Morvarid Soltani-Bejnood
NQNeil Quigley
Neil Quigley
ASArnold Saxton
Arnold Saxton
Despite its potential importance in obesity and related disorders, little is known about regulation of lipogenesis in human adipose tissue. To investigate this area at the molecular and mechanistic levels, we studied lipogenesis and the regulation of 1 of its core enzymes, fatty acid synthase (FAS), in human adipose tissue in response to hormonal and nutritional manipulation. As a paradigm for lipogenic genes, we cloned the upstream region of the human FAS gene, compared its sequence to that of FAS orthologs from other species, and identified important regulatory elements that lie upstream of the FAS coding region. Lipogenesis, as assessed by glucose incorporation into lipids, was increased by insulin and more so by the combination of insulin and dexamethasone (Dex, a potent glucocorticoid analogue). In parallel, FAS expression, activity, and gene transcription rate were also significantly increased by these treatments. We also showed that linoleic acid, a representative PUFA, attenuated the actions of insulin and Dex on fatty acid and lipid synthesis as well as FAS activity and expression. Using reporter assays, we determined that the regions responsible for hormonal regulation of the FAS gene lie in the proximal portion of the gene's 5′-flanking region, within which we identified an insulin response element similar to the E-box sequence we identified previously in the rat FAS gene. In summary, we demonstrated that lipogenesis occurs in human adipose tissue and can be induced by insulin, further enhanced by glucocorticoids, and suppressed by PUFA in a hormone-dependent manner.

1 May 2013 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
PFPelagie M. Favi
Pelagie M. Favi
RBRoberto S. Benson
Roberto S. Benson
NNNancy R. Neilsen
Nancy R. Neilsen
RHRyan L. Hammonds
Ryan L. Hammonds
CBCassandra C. Bates
Cassandra C. Bates
Madhu DharMadhu Dhar
Madhu Dhar

1 April 2004 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
Madhu DharMadhu Dhar
Madhu Dhar
CSCarla S. Sommardahl
Carla S. Sommardahl
TKTanisa Kirkland
Tanisa Kirkland
SNSarah Nelson
Sarah Nelson
RDRobert Donnell
Robert Donnell
LCLawrence W. Castellani
Lawrence W. Castellani
Atp10c is a novel type IV P-type ATPase and is a putative phospholipid transporter. The purpose of this study was to assess the overall effect of the heterozygous deletion of Atp10c on obesity-related phenotypes and metabolic abnormalities in mice fed a high-fat diet. Heterozygous mice with maternal inheritance of Atp10c were compared with heterozygous mice with paternal inheritance of Atp10c and wild-type controls. Body weight, adiposity index, and plasma insulin, leptin and triglyceride concentrations were significantly greater in the mutants inheriting the deletion maternally compared with their sex- and age-matched control male mice fed a 10% fat (% energy) diet and female mice fed a 45% fat (% energy) diet. Glucose and insulin tolerance tests were performed after mice consumed the diets for 4 and 8 wk. Mutants had altered glucose tolerance and insulin response compared with controls, suggesting insulin resistance in both sexes. Mice were killed at 12 wk and routine gross and histological evaluations of the liver, pancreas, adipose tissue, and heart were performed. Histological evaluation showed micro- and macrovesicular lipid deposition within the hepatocytes that was more severe in the mutant mice than in age-matched controls. Although sex differences were observed, our data suggest that heterozygous deletion along with an unusual pattern of maternal inheritance of the chromosomal region containing the single gene, Atp10c, causes obesity, type 2 diabetes, and nonalcoholic fatty liver disease in these mice.

4 April 2005 in Respiratory Research
Verified
Journal Article
Open access
HPHoward K Plummer
Howard K Plummer
Madhu DharMadhu Dhar
Madhu Dhar
HSHildegard Schuller
Hildegard Schuller
Background: We and others have shown that one of the mechanisms of growth regulation of small cell lung cancer cell lines and cultured pulmonary neuroendocrine cells is by the binding of agonists to the α7 neuronal nicotinic acetylcholine receptor. In addition, we have shown that the nicotine-derived carcinogenic nitrosamine, 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), is a high affinity agonist for the α7 nicotinic acetylcholine receptor. In the present study, our goal was to determine the extent of α7 mRNA and protein expression in the human lung. Methods: Experiments were done using reverse transcription polymerase chain reaction (RT-PCR), a nuclease protection assay and western blotting using membrane proteins. Results: We detected mRNA for the neuronal nicotinic acetylcholine receptor α7 receptor in seven small cell lung cancer (SCLC) cell lines, in two pulmonary adenocarcinoma cell lines, in cultured normal human small airway epithelial cells (SAEC), one carcinoid cell line, three squamous cell lines and tissue samples from nine patients with various types of lung cancer. A nuclease protection assay showed prominent levels of α7 in the NCI-H82 SCLC cell line while α7 was not detected in SAEC, suggesting that α7 mRNA levels may be higher in SCLC compared to normal cells. Using a specific antibody to the α7 nicotinic receptor, protein expression of α7 was determined. All SCLC cell lines except NCI-H187 expressed protein for the α7 receptor. In the non-SCLC cells and normal cells that express the α7 nAChR mRNA, only in SAEC, A549 and NCI-H226 was expression of the α7 nicotinic receptor protein shown. When NCI-H69 SCLC cell line was exposed to 100 pm NNK, protein expression of the α7 receptor was increased at 60 and 150 min. Conclusion: Expression of mRNA for the neuronal nicotinic acetylcholine receptor α7 seems to be ubiquitously expressed in all human lung cancer cell lines tested (except for NCI-H441) as well as normal lung cells. The α7 nicotinic receptor protein is expressed in fewer cell lines, and the tobacco carcinogen NNK increases α7 nicotinic receptor protein levels.

1 June 2005 in Mammalian Genome
Verified
Journal Article
Closed access
PDF file
FDFeng Ding
Feng Ding
YPYelena Prints
Yelena Prints
Madhu DharMadhu Dhar
Madhu Dhar
DJDabney K. Johnson
Dabney K. Johnson
CMCarmen Garnacho Montero
Carmen Garnacho Montero
UFUta Francke
Uta Francke